Kura Oncology, Inc.·4

Aug 16, 4:09 PM ET

Powl Brian T. 4

4 · Kura Oncology, Inc. · Filed Aug 16, 2023

Insider Transaction Report

Form 4
Period: 2023-08-14
Powl Brian T.
Chief Commercial Officer
Transactions
  • Award

    Option to purchase common stock

    2023-08-14+200,000200,000 total
    Exercise: $11.72Exp: 2033-08-13Common Stock (200,000 underlying)
Footnotes (1)
  • [F1]1/4th of the shares vest on the one year anniversary of the vesting commencement date, and 1/48th of the shares vest in 36 monthly installments thereafter.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION